The lab is interested in designing novel drugs targeting cancer cells while sparing normal cells. A host of ligands have been collected that will be modified by medicinal chemistry. To ensure the ligand:enzyme interactions are not destroyed by the modifications, molecular modeling will be performed. We will perform molecular dynamic stimulations and MMGBSA free energy calculations to evaluate the ligand and protein interaction in addition to ligand docking. To enhance the programs' speed and hence capacity we request access to the supercomputing powers of Arrhenius.